NEW YORK, Jan. 24, 2012 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) will host an Investor Day on Feb. 21, in New York City.   Robert J. Coury, Mylan's executive chairman; Heather Bresch, chief executive officer; Rajiv Malik, president; Hal Korman, chief operating officer; John Sheehan, chief financial officer; and John Thievon, president of Dey Pharma,  will present the company's financial guidance for 2012 and an overview of the company's strategic vision and growth strategy for 2013 and beyond.  They will be joined by Tony Mauro, president of North America, and Didier Barret, president of Mylan's Europe, Middle East and Africa operations, for a question and answer session.

The presentations will be broadcast live via webcast beginning at 1 p.m. ET.  The meeting is expected to conclude by 5 p.m. ET. 

The company will issue its fourth quarter and full-year 2011 earnings results before the market opens on Feb. 21.

To access the live webcast and view the accompanying slide presentations, visit the Investor Relations section of Mylan's website, at http://investor.mylan.com, at least 15 minutes before the presentation is scheduled to begin; click on the webcast icon to register and download or install any necessary software.  If you are unable to view the live webcast, a replay will be available for 30 days on Mylan's website after the event's conclusion.

Mylan Inc. ranks among the leading generic and specialty pharmaceutical companies in the world and provides products to customers in more than 150 countries and territories. The company maintains one of the industry's broadest and highest quality product portfolios supported by a robust product pipeline; operates one of the world's largest active pharmaceutical ingredient manufacturers; and runs a specialty business focused on respiratory, allergy and psychiatric therapies. For more information about Mylan, please visit www.mylan.com. For more information about generic drugs, please visit www.ChoosingGenerics.com.

SOURCE Mylan Inc.